| 영문 | atropine | 한글 | 아트로핀 |
|---|---|---|---|
| 설명 | 신경전달물질의 한 가지로 근육을 지배하는 신경의 말단에서 분비되어 근육의 수축을 유도하기도 하며, 부교감신경의 말단에서 분비되어 부교감신경의 전달을 담당하기도 하고, 뇌의 신경세포에서도 분비되어 여러가지 작용을 하는 아세틸콜린이라는 물질의 역할을 차단하는 물질이다. |
||
| ACT | achievement through counseling and treatment; actin; actinomycin; activated clotting time; advanced ... |
|---|---|
| AS | acetylstrophanthidin; acidified serum; acoustic schwannoma; acoustic stimulation; active sarcoidosis... |
| AT | abdominal thrusts; achievement test; Achilles tendon; Achard-Thiers [syndrome]; adaptive thermogenes... |
| LANE | lidocaine, atropine, naloxone, epinephrine [drugs that may be administered via endotracheal tube] |
| NAVEL | naloxone, atropine, Valium, epinephrine, lidocaine |
| DBcyclic AMP | Dibutyryl cyclic AMP |
|---|---|
| A | Atropine |
| AT | Atropine |
| ATR | Atropine |
| DASE | Dobutamine atropine stress echocardiography |
| atropine | <drug> A toxic alkaloid extracted from belladonna and other members of thenightshade family, it is typically used to dilate the eye and to stopmuscular spasms. Pharmacologic action: Parasympatholytic. Competitive blockade of acetylcholine at muscarinic receptors. Increases sinus node automaticity and AV conduction. Uses: Treat bradycardia, asystole, and AV block Dose: 0.5 - 1.0 mg for bradycardia every 3 - 5 min to a total dose of 0.04 mg/kg. Doses smaller than 0.5 mg can cause a paradoxical bradycardia due to sympathomimetic effects Typically 3 mg is adequate to completely block vagal effects Atropine is well absorbed via endotracheal route - administer 1-2 mg diluted in 10 mL sterile water or normal saline. Potential complications: 1. Tachyarrhythmias 2. Exacerbation of myocardial ischemia 3. Low dose may cause paradoxical bradycardia 4. Dry mouth, urinary retention, flushed and hot skin 5. Crosses blood-brain barrier which can cause delirium Note: The denervated heart will not respond to atropine. (15 Mar 2000) |
|---|---|
| atropine dehydrase | <enzyme> Proposed mechanism for conversion of atropine or scopolamine to apoatropine or aposcopolamine via a mechanism using hydroxysteroid sulfotransferase by guinea pig liver Registry number: EC 2.8.2.- Synonym: scopolamine dehydrase (26 Jun 1999) |
| atropine derivatives | Analogs and derivatives of atropine. (12 Dec 1998) |
| atropine methonitrate | The methylnitrate of atropine, with the same actions and uses as atropine, but less lipid-soluble and hence with fewer central nervous system effects; a quaternary compound. (05 Mar 2000) |
| atropine methylbromide | A quaternary derivative of atropine that is less lipid soluble and hence produces fewer central nervous system actions; a cycloplegic. Synonym: atropine methylbromide. (05 Mar 2000) |
| atropine sulfate | An anticholinergic; a widely used soluble salt of atropine. (05 Mar 2000) |
| atropine test | If an injection of atropine relieves bradycardia, the condition is due to action of the vagus; if it does not, the condition may be due to an affection of the heart itself. Synonym: atropine test. (05 Mar 2000) |
| AMP | <abbreviation> Adenosine monophosphate; specifically, the 5'-monophosphate unless modified by a numerical prefix. See: adenylic acid. (05 Mar 2000) |
| AMP-activated protein kinase kinase | <enzyme> An endogenous kinase kinase; reactivates the inactive form of AMP-activated protein kinase (AMP-pk); phosphorylates the 63-kD subunit of AMP-pk Registry number: EC 2.7.1.- Synonym: AMP-pk reactivator, hmg CoA reductase kinase kinase (26 Jun 1999) |
| AMP deaminase | <enzyme> An enzyme that catalyses the deamination of AMP to imp. Chemical name: AMP aminohydrolase Registry number: EC 3.5.4.6 (12 Dec 1998) |
| receptors, cyclic AMP | Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behaviour of cells. The best characterised cyclic AMP receptors are those of the slime mold dictyostelium discoideum. The transcription regulator cyclic AMP receptor protein of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of cyclic AMP-dependent protein kinases. (12 Dec 1998) |
| polyphosphate AMP phosphotransferase | <enzyme> From acinetobacter; catalyses (polyphosphate)n and AMP to (polyphosphate)n-1 and ADP Registry number: EC 2.7.4.- Synonym: pamp phosphotransferase (26 Jun 1999) |
| cyclic AMP | <molecular biology> 3'5' cyclic ester of AMP. The first second messenger hormone signalling system to be characterised. Generated from ATP by the action of adenyl cyclase that is coupled to hormone receptors by G-proteins (GTP-binding proteins). CAMP activates a specific (cAMP dependent) protein kinase and is inactivated by phosphodiesterase action giving 5'AMP. Also functions as an extracellular morphogen for some slime moulds. (18 Nov 1997) |
| cyclic AMP-dependent protein kinase | Enzymes which attach phosphate groups to the serine or tyrosine amino acids on proteins as a means of regulating the proteins' activity in metabolic reactions. (09 Oct 1997) |
| cyclic AMP-dependent protein kinases | <enzyme> A group of enzymes that are dependent on cyclic AMP and catalyze the phosphorylation of serine or threonine residues on proteins. Registry number: EC 2.7.10.- (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
휴온스황산아트로핀주사액 - 새창
|
휴온스 |
A29500211 | Atropine Sulfate | 전문의약품 | 급여 | 분업예외의약품 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|